Last updated 2026-07-26
Total raised
—
Last: Undisclosed Round 2024-07
Stage
Series D
Founded
2009
Headcount
36
HQ
Pardes Hanna-Karkur, Israel
Sector
Health Tech & Life Sciences
About
RedDress is a private medical device company that has developed innovative autologous wound care solutions, primarily its ActiGraft product family, which creates an in-vitro blood clot from a patient's own whole blood to treat chronic, non-healing wounds. The company is committed to ongoing research and development to deliver advanced healing solutions.
Headcount over time
36 employees (2026-09) · 1 point
Offices
Pardes Hanna-Karkur, Israel · HQ / main office
Show all offices (1 more)
- Ponte Vedra Beach, United States
Q&A
- What is RedDress's primary product?
- RedDress's primary product is ActiGraft, an autologous wound care solution that creates an in-vitro blood clot from a patient's own whole blood to treat chronic, non-healing wounds.
- When did RedDress receive FDA 510(k) clearance for its RD1 System?
- RedDress received FDA 510(k) clearance for its RD1 System on July 10, 2018.
- Which investors participated in RedDress's Series D round?
- RedDress's Series D round in May 2023 included investments from ATHOS Biopharma GmbH.
- How many employees does RedDress currently have?
- RedDress has 36 employees, falling within the 11-50 employee bucket.
- What is the total amount of funding RedDress has raised to date?
- RedDress has raised a total of $43,000,000 to date.
- What is the current status of RedDress's ActiGraft PRO in the US market?
- In July 2023, RedDress launched ActiGraft PRO with G-Code Reimbursement Status for the US wound care market.
- Has RedDress secured any strategic partnerships recently?
- In October 2021, RedDress earned a strategic partnership with MediGroup.
Team · 6
Alon Kushnir
Founder · CEO
Dr. Igal Kushnir
Founder · Founder & Medical Director
Neomi Weisblumm
Chief Financial Officer
Robert Mueller
General Manager, USA
Sharon Sirota
Clinical Team Leader
Moshe Lichtenstein
Director, International Business Development
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2B2CB2BB2C
Highlights
1 Patents
Tags
pain-reliefhealthcare-providersdiabeteschronic-painmedical-devicesregenerative-medicinemedical-technologies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | reddressmedical.com/ |
|---|---|
| linkedin.com/company/11201697 | |
| facebook.com/RedDressLtd1 | |
| YouTube | youtube.com/channel/UCACueHkotGCG0JFbsnR5Frg?view_as=subscri |
Identifiers & details
| Founded | 2009 |
|---|---|
| Employees (exact) | 36 |
| Offices | Ponte Vedra Beach |
Radar intelligence
Patents
| EPO | 21 |
|---|
Publications (Crossref)
| Works | 2 |
|---|
Web history (Wayback)
| Domain | reddressmedical.com |
|---|
Certificate / subdomain footprint
| Subdomains | 11 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514264811 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2009-04-23 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 3 — annual_report (1), charge (2) |
| Registered address | שקדים 11 פרדס חנה-כרכור |
Recent registry events
| Date | Event |
|---|---|
| 2026-03-12 | דו~ח שנתי |
| 2026-01-06 | סילוק שעבוד |
| 2026-01-06 | סילוק שעבוד |